Psychedelic Funding Update: Q3 2024
We have updated our Psychedelic Company Financing Tracker to reflect activity in Q3 2024. You can explore the interactive charts here.
2024 got off to a roaring start, with over $600M raised in the first half of the year. However, the majority of that inflow happened in Q1, with a 60% drop-off in Q2.
Q3 has seen funding slow even further, with inflows down to around $37.5M for the quarter: a 90% decrease since Q1 and a nearly 80% drop from Q2. Aside from Q4 2023, when inflows dropped to a low of just over $16M, we haven’t seen levels like this since Q1 2020...
Join Today
Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and research.
- Regular Bulletins featuring news, analysis, and research
- Articles and deep dives across psychedelic drug development, policy, and research
- Exclusive interviews with researchers, executives, and policymakers
- Bespoke resources and tools including the Psychedelic Bill Tracker
- Quarterly video briefings and slide decks